Recent studies indicated that SNHG14 functioned as a tumor promoter by sponging different miRNAs in a series of cancers, such as retinoblastoma, pancreatic ductal adenocarcinoma, and osteosarcoma (Hou and Mao, 2020; Sun et al., 2020; Xie et al., 2020). The gene discussed is SNHG14; the disease is retinoblastoma.